• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于筛查高环境氡暴露地区肺癌风险的潜在血清生物标志物:一项初步研究。

A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study.

作者信息

Autsavapromporn Narongchai, Klunklin Pitchayaponne, Chitapanarux Imjai, Jaikang Churdsak, Chewaskulyong Busyamas, Sripan Patumrat, Hosoda Masahiro, Tokonami Shinji

机构信息

Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

Toxicology Section, Department of Forensic Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Life (Basel). 2021 Nov 21;11(11):1273. doi: 10.3390/life11111273.

DOI:10.3390/life11111273
PMID:34833148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8625497/
Abstract

Radon is a major cause of lung cancer (LC) deaths among non-smokers worldwide. However, no serum biomarker for screening of LC risk in high residential radon (HRR) areas is available. Therefore, the aim of this study was to determine diagnostic values of serum carcinoembryonic antigen (CEA), cytokeratin 19 fragment (Cyfra21-1), human epididymis protein 4 (HE4), interleukin 8 (IL-8), migration inhibitory factor (MIF), tumor nuclear factor-alpha (TNF-α) and vascular endothelial growth factors (VEGF) occurring in high radon areas. Seventy-five LC non-smoker patients and seventy-five healthy controls (HC) were enrolled in this study. Among the HC groups, twenty-five HC were low residential radon (LRR) and fifty HC were HRR. Significantly higher ( < 0.0004) serum levels of CEA, Cyfra21-1, IL-8 and VEGF were found in the LC compared with the LRR and HRR groups. More importantly, significantly higher levels ( < 0.009) of serum CEA, Cyfra21-1 and IL-8 were observed in HRR compared with the LRR group. Likewise, a ROC curve demonstrated that serum CEA and Cyfra21-1 could better distinguish LC risk from HRR groups than IL-8. These results indicated that serum CEA and Cyfra21-1 were significantly increased in the HRR group and may be considered as potential biomarkers for individuals at high-risk to develop LC.

摘要

氡是全球非吸烟者肺癌(LC)死亡的主要原因。然而,目前尚无用于筛查高居住氡(HRR)地区LC风险的血清生物标志物。因此,本研究的目的是确定血清癌胚抗原(CEA)、细胞角蛋白19片段(Cyfra21-1)、人附睾蛋白4(HE4)、白细胞介素8(IL-8)、迁移抑制因子(MIF)、肿瘤核因子-α(TNF-α)和血管内皮生长因子(VEGF)在高氡地区的诊断价值。本研究纳入了75例非吸烟LC患者和75例健康对照(HC)。在HC组中,25例HC为低居住氡(LRR),50例HC为HRR。与LRR组和HRR组相比,LC组血清CEA、Cyfra21-1、IL-8和VEGF水平显著升高(<0.0004)。更重要的是,与LRR组相比,HRR组血清CEA、Cyfra21-1和IL-8水平显著升高(<0.009)。同样,ROC曲线表明,血清CEA和Cyfra21-1比IL-8能更好地区分HRR组的LC风险。这些结果表明,HRR组血清CEA和Cyfra21-1显著升高,可被视为发生LC高危个体的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/ea1f279effba/life-11-01273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/7232c6bae60a/life-11-01273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/fae2af6f73c0/life-11-01273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/1f0df3359b3a/life-11-01273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/ea1f279effba/life-11-01273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/7232c6bae60a/life-11-01273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/fae2af6f73c0/life-11-01273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/1f0df3359b3a/life-11-01273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e73/8625497/ea1f279effba/life-11-01273-g004.jpg

相似文献

1
A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study.一种用于筛查高环境氡暴露地区肺癌风险的潜在血清生物标志物:一项初步研究。
Life (Basel). 2021 Nov 21;11(11):1273. doi: 10.3390/life11111273.
2
The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.血清人附睾蛋白4在肺癌诊断中的应用价值
Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2405-2407. doi: 10.31557/APJCP.2019.20.8.2405.
3
Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.胸苷激酶1联合癌胚抗原、细胞角蛋白19片段和神经元特异性烯醇化酶可提高其对肺癌的诊断价值。
Life Sci. 2018 Feb 1;194:1-6. doi: 10.1016/j.lfs.2017.12.020. Epub 2017 Dec 14.
4
Detection of serum HE4 levels contributes to the diagnosis of lung cancer.检测血清人附睾蛋白4(HE4)水平有助于肺癌的诊断。
Oncol Lett. 2023 Apr 27;25(6):255. doi: 10.3892/ol.2023.13841. eCollection 2023 Jun.
5
[Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].[血清癌胚抗原和细胞角蛋白19片段水平在手术前后的变化对非小细胞肺癌患者预后的影响]
Zhongguo Fei Ai Za Zhi. 2015 Jun;18(6):358-64. doi: 10.3779/j.issn.1009-3419.2015.06.05.
6
Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma.血清肿瘤标志物细胞角蛋白19片段(Cyfra21-1)、鳞状细胞癌抗原(SCCAg)、铁蛋白、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)及甲胎蛋白(AFP)在口腔/口咽鳞状细胞癌中的诊断价值
Onco Targets Ther. 2016 Jun 3;9:3381-6. doi: 10.2147/OTT.S105672. eCollection 2016.
7
[The diagnostic significance of single or combination lung cancer-related serum biomarkers in high risk lung cancer patients].[单一或联合肺癌相关血清生物标志物在高危肺癌患者中的诊断意义]
Zhonghua Nei Ke Za Zhi. 2016 Jan;55(1):25-30. doi: 10.3760/cma.j.issn.0578-1426.2016.01.007.
8
Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.血清唾液酸 Lewis x 和细胞角蛋白 19 片段作为 I 期非小细胞肺癌患者复发的预测因素。
Lung Cancer. 2007 Dec;58(3):369-75. doi: 10.1016/j.lungcan.2007.07.002. Epub 2007 Aug 13.
9
Value of serum marker HE4 in pulmonary carcinoma diagnosis.血清标志物HE4在肺癌诊断中的价值。
Int J Clin Exp Med. 2015 Oct 15;8(10):19014-21. eCollection 2015.
10
Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer.血清和胸水癌胚抗原及细胞角蛋白19片段在非小细胞肺癌伴胸腔积液患者中的诊断价值
J Carcinog. 2015 Nov 27;14:7. doi: 10.4103/1477-3163.170662. eCollection 2015.

引用本文的文献

1
Systematic Review and Meta-Analysis of Inflammatory Biomarkers in Individuals Exposed to Radon.氡暴露个体炎症生物标志物的系统评价与Meta分析
Biomedicines. 2025 Feb 17;13(2):499. doi: 10.3390/biomedicines13020499.
2
Serum biomarkers associated with health impacts of high residential radon exposure: a metabolomic pilot study.与高住宅氡暴露对健康影响相关的血清生物标志物:一项代谢组学初步研究。
Sci Rep. 2025 Feb 11;15(1):5099. doi: 10.1038/s41598-025-89753-z.
3
Biomarkers of lung cancer for screening and in never-smokers-a narrative review.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Development of radon transport model in different types of dwellings to assess indoor activity concentration.开发不同类型住宅中的氡迁移模型,以评估室内活动浓度。
J Environ Radioact. 2021 Feb;227:106501. doi: 10.1016/j.jenvrad.2020.106501. Epub 2020 Dec 9.
3
Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients.
用于肺癌筛查及从不吸烟者的生物标志物——一篇叙述性综述
Transl Lung Cancer Res. 2023 Oct 31;12(10):2129-2145. doi: 10.21037/tlcr-23-291. Epub 2023 Oct 25.
4
Circulating proteome for pulmonary nodule malignancy.循环蛋白质组学在肺结节良恶性诊断中的应用
J Natl Cancer Inst. 2023 Sep 7;115(9):1060-1070. doi: 10.1093/jnci/djad122.
5
Current treatments for non-small cell lung cancer.非小细胞肺癌的当前治疗方法。
Front Oncol. 2022 Aug 11;12:945102. doi: 10.3389/fonc.2022.945102. eCollection 2022.
6
Health Effects of Natural Environmental Radiation during Burning Season in Chiang Mai, Thailand.泰国清迈燃烧季节期间自然环境辐射对健康的影响。
Life (Basel). 2022 Jun 8;12(6):853. doi: 10.3390/life12060853.
非转移性肺癌患者随访后基于年龄和血清分析物的转移预后
Transl Oncol. 2021 Jan;14(1):100933. doi: 10.1016/j.tranon.2020.100933. Epub 2020 Nov 11.
4
Lung Cancer in Thailand.泰国的肺癌
J Thorac Oncol. 2020 Nov;15(11):1714-1721. doi: 10.1016/j.jtho.2020.04.024. Epub 2020 Oct 23.
5
Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma.非小细胞肺癌患者的广泛血清生物标志物分析。
Cytokine. 2020 Feb;126:154868. doi: 10.1016/j.cyto.2019.154868. Epub 2019 Oct 16.
6
IDENTIFICATION OF NOVEL BIOMARKERS FOR LUNG CANCER RISK IN HIGH LEVELS OF RADON BY PROTEOMICS: A PILOT STUDY.蛋白质组学鉴定高氡水平下肺癌风险的新型生物标志物:一项初步研究。
Radiat Prot Dosimetry. 2019 Oct 1;184(3-4):496-499. doi: 10.1093/rpd/ncz064.
7
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab.血清蛋白水平对接受纳武利尤单抗治疗的晚期非小细胞肺癌患者的预测价值。
Lung Cancer. 2019 Jun;132:107-113. doi: 10.1016/j.lungcan.2019.03.020. Epub 2019 Mar 22.
8
Short Telomere Length as a Biomarker Risk of Lung Cancer Development Induced by High Radon Levels: A Pilot Study.短端粒长度作为高氡水平诱导肺癌发展的生物标志物风险:一项初步研究。
Int J Environ Res Public Health. 2018 Sep 30;15(10):2152. doi: 10.3390/ijerph15102152.
9
Risk patterns of lung cancer mortality in northern Thailand.泰国北部肺癌死亡率的风险模式。
BMC Public Health. 2018 Sep 24;18(1):1138. doi: 10.1186/s12889-018-6025-1.
10
Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9.基于血清血管内皮生长因子(Vegf)、白细胞介素-8(Il-8)和基质金属蛋白酶-9(MMP-9)对肺癌及其转移与慢性阻塞性肺疾病的鉴别诊断
Sci Rep. 2016 Nov 4;6:36065. doi: 10.1038/srep36065.